Cargando…
SOCS3 Genetic Polymorphism Is Associated With Clinical Features and Prognosis of Hepatocellular Carcinoma Patients Receiving Hepatectomy
Previous studies showed that suppressor of cytokine signaling 3 (SOCS3) protein is associated with incidence and progression of hepatocellular carcinoma (HCC); however, the association between the genetic polymorphism of SOCS3 gene and HCC remains unknown. A total of 254 HCC patients and 354 healthy...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616756/ https://www.ncbi.nlm.nih.gov/pubmed/26447993 http://dx.doi.org/10.1097/MD.0000000000001344 |
_version_ | 1782396705549844480 |
---|---|
author | Jiang, Bei-ge Yang, Yuan Liu, Hui Gu, Fang-ming Yang, Yun Zhao, Lin-Hao Yuan, Sheng-xian Wang, Ruo-yu Zhang, Jin Zhou, Wei-ping |
author_facet | Jiang, Bei-ge Yang, Yuan Liu, Hui Gu, Fang-ming Yang, Yun Zhao, Lin-Hao Yuan, Sheng-xian Wang, Ruo-yu Zhang, Jin Zhou, Wei-ping |
author_sort | Jiang, Bei-ge |
collection | PubMed |
description | Previous studies showed that suppressor of cytokine signaling 3 (SOCS3) protein is associated with incidence and progression of hepatocellular carcinoma (HCC); however, the association between the genetic polymorphism of SOCS3 gene and HCC remains unknown. A total of 254 HCC patients and 354 healthy controls were enrolled. All HCC patients underwent partial hepatectomy as initial treatment and were followed. Three SOCS3 gene polymorphisms, namely, rs4969170 A>G, rs8064821 C>T, and rs12953258 C>A were determined. Our data show that the rs4969170 A>G polymorphism dramatically affects the susceptibility to HCC in our cohorts. Logistic regression analyses revealed that the rs4969170 GG is a risk factor for HCC after the adjustment with confounding factors. The rs4969170A>G polymorphism is also associated with the clinical features of HCC patients and predicts the postoperative relapse-free survival and overall survival. The rs4969170GG genotype carrier had a worse prognosis than the rs4969170AG and rs4969170AA carrier. Our findings suggest that the rs4969170A>G polymorphism of SOCS3 gene may be used as a prognostic predictor for HCC patients who underwent surgical treatment. |
format | Online Article Text |
id | pubmed-4616756 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-46167562015-10-27 SOCS3 Genetic Polymorphism Is Associated With Clinical Features and Prognosis of Hepatocellular Carcinoma Patients Receiving Hepatectomy Jiang, Bei-ge Yang, Yuan Liu, Hui Gu, Fang-ming Yang, Yun Zhao, Lin-Hao Yuan, Sheng-xian Wang, Ruo-yu Zhang, Jin Zhou, Wei-ping Medicine (Baltimore) 5700 Previous studies showed that suppressor of cytokine signaling 3 (SOCS3) protein is associated with incidence and progression of hepatocellular carcinoma (HCC); however, the association between the genetic polymorphism of SOCS3 gene and HCC remains unknown. A total of 254 HCC patients and 354 healthy controls were enrolled. All HCC patients underwent partial hepatectomy as initial treatment and were followed. Three SOCS3 gene polymorphisms, namely, rs4969170 A>G, rs8064821 C>T, and rs12953258 C>A were determined. Our data show that the rs4969170 A>G polymorphism dramatically affects the susceptibility to HCC in our cohorts. Logistic regression analyses revealed that the rs4969170 GG is a risk factor for HCC after the adjustment with confounding factors. The rs4969170A>G polymorphism is also associated with the clinical features of HCC patients and predicts the postoperative relapse-free survival and overall survival. The rs4969170GG genotype carrier had a worse prognosis than the rs4969170AG and rs4969170AA carrier. Our findings suggest that the rs4969170A>G polymorphism of SOCS3 gene may be used as a prognostic predictor for HCC patients who underwent surgical treatment. Wolters Kluwer Health 2015-10-09 /pmc/articles/PMC4616756/ /pubmed/26447993 http://dx.doi.org/10.1097/MD.0000000000001344 Text en Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 |
spellingShingle | 5700 Jiang, Bei-ge Yang, Yuan Liu, Hui Gu, Fang-ming Yang, Yun Zhao, Lin-Hao Yuan, Sheng-xian Wang, Ruo-yu Zhang, Jin Zhou, Wei-ping SOCS3 Genetic Polymorphism Is Associated With Clinical Features and Prognosis of Hepatocellular Carcinoma Patients Receiving Hepatectomy |
title | SOCS3 Genetic Polymorphism Is Associated With Clinical Features and Prognosis of Hepatocellular Carcinoma Patients Receiving Hepatectomy |
title_full | SOCS3 Genetic Polymorphism Is Associated With Clinical Features and Prognosis of Hepatocellular Carcinoma Patients Receiving Hepatectomy |
title_fullStr | SOCS3 Genetic Polymorphism Is Associated With Clinical Features and Prognosis of Hepatocellular Carcinoma Patients Receiving Hepatectomy |
title_full_unstemmed | SOCS3 Genetic Polymorphism Is Associated With Clinical Features and Prognosis of Hepatocellular Carcinoma Patients Receiving Hepatectomy |
title_short | SOCS3 Genetic Polymorphism Is Associated With Clinical Features and Prognosis of Hepatocellular Carcinoma Patients Receiving Hepatectomy |
title_sort | socs3 genetic polymorphism is associated with clinical features and prognosis of hepatocellular carcinoma patients receiving hepatectomy |
topic | 5700 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616756/ https://www.ncbi.nlm.nih.gov/pubmed/26447993 http://dx.doi.org/10.1097/MD.0000000000001344 |
work_keys_str_mv | AT jiangbeige socs3geneticpolymorphismisassociatedwithclinicalfeaturesandprognosisofhepatocellularcarcinomapatientsreceivinghepatectomy AT yangyuan socs3geneticpolymorphismisassociatedwithclinicalfeaturesandprognosisofhepatocellularcarcinomapatientsreceivinghepatectomy AT liuhui socs3geneticpolymorphismisassociatedwithclinicalfeaturesandprognosisofhepatocellularcarcinomapatientsreceivinghepatectomy AT gufangming socs3geneticpolymorphismisassociatedwithclinicalfeaturesandprognosisofhepatocellularcarcinomapatientsreceivinghepatectomy AT yangyun socs3geneticpolymorphismisassociatedwithclinicalfeaturesandprognosisofhepatocellularcarcinomapatientsreceivinghepatectomy AT zhaolinhao socs3geneticpolymorphismisassociatedwithclinicalfeaturesandprognosisofhepatocellularcarcinomapatientsreceivinghepatectomy AT yuanshengxian socs3geneticpolymorphismisassociatedwithclinicalfeaturesandprognosisofhepatocellularcarcinomapatientsreceivinghepatectomy AT wangruoyu socs3geneticpolymorphismisassociatedwithclinicalfeaturesandprognosisofhepatocellularcarcinomapatientsreceivinghepatectomy AT zhangjin socs3geneticpolymorphismisassociatedwithclinicalfeaturesandprognosisofhepatocellularcarcinomapatientsreceivinghepatectomy AT zhouweiping socs3geneticpolymorphismisassociatedwithclinicalfeaturesandprognosisofhepatocellularcarcinomapatientsreceivinghepatectomy |